Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
نویسندگان
چکیده
1 McCuaig CC, Vera C, Kokta V et al. Connective tissue nevi in children: institutional experience and review. J Am Acad Dermatol 2012 (Nov); 67: 890–897. 2 Uitto J, Santa Cruz DJ, Eisen AZ. Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J Am Acad Dermatol 1980 (Nov); 3: 441–461. 3 Nelson AA, Ruben BS. Isolated plantar collagenoma not associated with Proteus syndrome. J Am Acad Dermatol 2008 (Mar); 58: 497–499. 4 Turner JT, Cohen MM Jr, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A 2004 (Oct 1); 130A: 111–122. 5 Schwartz RA, Fernandez G, Kotulska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 2007 (Aug); 57: 189–202. 6 Lucas Costa A, Betlloch I, Perez-Crespo M, Mataix J, Banuls J. Mammary skin tag in a 2-year-old girl: a long-lasting adnexal polyp of neonatal skin? Pediatr Dermatol 2009 (Sep–Oct); 26: 618–620.
منابع مشابه
Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site. Here, we have a case where both disorders were reported to present in the same patient. Diphenylcyclopropenone (diphencyprone, DCP) is used in the treatment of alopecia areata and may induce vitiligo in some...
متن کاملA review of immunologic factors involved in alopecia areata and the effects of diphencyprone on these factors
Alopecia areata (AA) is a sudden non-scarring hair loss that can be seen in any hairy area in the form of round or oval patches. It is an autoimmune disorder with an immunological response against hair follicles that is caused by genetic and environmental factors. The prevalence of AA is about 0.1% to 0.2% worldwide. Depending on the severity of the disease and sites of involvement, it can be d...
متن کاملDPCP for the treatment of alopecia areata.
Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice by many dermatologists. Although there have been no major side effects reported since its initial use, there remain some unknowns regarding its safety. Because DPCP has at least a 40% success rate for cosmetically acceptable regrowth in e...
متن کاملTopical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
BACKGROUND Highly variable results of topical diphenylcyclopropenone (DPCP) in the treatment of alopecia areata have been reported so far. The purposes of the present study were to evaluate the efficacy and tolerability of DPCP treatment in severe alopecia areata. METHODS Twenty-eight patients (16 female and 12 male, 10-35 years old, mean age 25 years) with extensive alopecia areata were enro...
متن کاملAlopecia areata: a revision and update Alopecia areata: revisão e atualização
Nowadays alopecia areata is considered an autoimmune disease with genetic substrate. The clinical, histopathological, therapeutic and possible physiopathological mechanisms are discussed. The therapeutic approach, especially for the severe forms is considered with emphasis on the methods based on immunomodulation by drugs, diphenylcyclopropenone and squaric acid dibutylester and its possible me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of dermatology
دوره 42 2 شماره
صفحات -
تاریخ انتشار 2015